GMP FOR NEW YORK CANNABINOID HEMP PROGRAM
On October 28, 2020, New York State Governor Andrew Cuomo announced that the New York State Department of Health (DOH) has filed proposed regulations to regulate the cannabinoid hemp industry. This program is expected to set quality control standards that all cannabinoid hemp processors and retailers will be required to meet to license their products called “GMP for New York Cannabinoid Hemp Program.”
Manufacturers and processors of cannabinoid hemp products in the New York State must go through a third-party audit to obtain and maintain Good Manufacturing Practice (GMP) Certification. This is a requirement to obtain New York State licensure for cannabis, CBD, and hemp companies.
Currently, the U.S. Food and Drug Administration (FDA) does not qualify CBD to be used in food or dietary supplements. New York’s proposed regulations are expected to fill the regulatory gap left by the lack of a national standard by the FDA.